Found 1825 results
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
L. E. Bermudez, Parker, A., and Goodman, J. R., Growth within macrophages increases the efficiency of Mycobacterium avium in invading other macrophages by a complement receptor-independent pathway., Infection and immunity, vol. 65, no. 5, pp. 1916-25, 1997.
L. E. Bermudez, [Post-antibiotic effect in the treatment of infections in neutropenic patients]., Revista do Hospital das Clínicas, vol. 41, no. 2, pp. 76-9, 1986.
L. E. Bermudez, Nash, K. A., Petrofsky, M., Young, L. S., and Inderlied, C. B., Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model., The Journal of infectious diseases, vol. 174, no. 6, pp. 1218-22, 1996.
L. E. Bermudez and Yamazaki, Y., Effects of macrolides and ketolides on mycobacterial infections., Current pharmaceutical design, vol. 10, no. 26, pp. 3221-8, 2004.
L. E. Bermudez, Wu, M., Petrofsky, M., and Young, L. S., Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages., Infection and immunity, vol. 60, no. 10, pp. 4245-52, 1992.
L. E. Bermudez and Young, L. S., Ethanol augments intracellular survival of Mycobacterium avium complex and impairs macrophage responses to cytokines., The Journal of infectious diseases, vol. 163, no. 6, pp. 1286-92, 1991.
L. E. Bermudez and Petrofsky, M., Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells., Infection and immunity, vol. 67, no. 6, pp. 3108-11, 1999.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., and Young, L. S., Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice., Antimicrobial agents and chemotherapy, vol. 38, no. 12, pp. 2717-21, 1994.
L. E. Bermudez and Young, L. S., Killing of Mycobacterium avium: insights provided by the use of recombinant cytokines., Research in microbiology, vol. 141, no. 2, pp. 241-3, 1990.
L. E. Bermudez, Wu, M., and Young, L. S., Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin., The Journal of infectious diseases, vol. 156, no. 3, pp. 510-3, 1987.
L. E. Bermudez and Inderlied, C. B., Effect of Mycobacterium avium infection on the influx, accumulation, and efflux of KRM-1648 by human macrophages., Microbial drug resistance (Larchmont, N.Y.), vol. 3, no. 3, pp. 277-82, 1997.
L. E. Bermudez and Champsi, J., Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice., Infection and immunity, vol. 61, no. 7, pp. 3093-7, 1993.
L. E. Bermudez, Petrofsky, M., Inderlied, C. B., and Young, L. S., Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice., The Journal of antimicrobial chemotherapy, vol. 36, no. 4, pp. 641-6, 1995.
L. E. Bermudez and Sangari, F. J., Mycobacterial invasion of epithelial cells., Sub-cellular biochemistry, vol. 33, pp. 231-49, 2000.
L. E. Bermudez and Young, L. S., Factors affecting invasion of HT-29 and HEp-2 epithelial cells by organisms of the Mycobacterium avium complex., Infection and immunity, vol. 62, no. 5, pp. 2021-6, 1994.
L. E. Bermudez, Parker, A., and Petrofsky, M., Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumour necrosis factor (TNF) and Fas, and involves the activation of caspases., Clinical and experimental immunology, vol. 116, no. 1, pp. 94-9, 1999.
L. E. Bermudez, Potential role of cytokines in disseminated mycobacterial infections., European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol. 13 Suppl 2, pp. S29-33, 1994.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Chee, C. B., Aralar, P., Petrofsky, M., Parman, T., Green, C. E., Lewin, A. H., Ellis, W. Y., and Young, L. S., Identification of (+)-Erythro-Mefloquine as an Active Enantiomer with Greater Efficacy than Mefloquine against Mycobacterium avium Infection in Mice., Antimicrobial agents and chemotherapy, vol. 56, no. 8, pp. 4202-6, 2012.
L. E. Bermudez, [Bacteremias in immunosuppressed patients]., Revista paulista de medicina, vol. 104, no. 2, pp. 87-92, 1986.
L. E. Bermudez and Young, L. S., Tumor necrosis factor alpha stimulates mycobactericidal/mycobacteriostatic activity in human macrophages by a protein kinase C-independent pathway., Cellular immunology, vol. 144, no. 2, pp. 258-68, 1992.
L. E. Bermudez, Petrofsky, M., Sommer, S., and Barletta, R. G., Peyer's patch-deficient mice demonstrate that Mycobacterium avium subsp. paratuberculosis translocates across the mucosal barrier via both M cells and enterocytes but has inefficient dissemination., Infection and immunity, vol. 78, no. 8, pp. 3570-7, 2010.
L. E. Bermudez and Kaplan, G., Recombinant cytokines for controlling mycobacterial infections., Trends in microbiology, vol. 3, no. 1, pp. 22-7, 1995.
L. E. Bermudez, Young, L. S., and Enkel, H., Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins., Infection and immunity, vol. 59, no. 5, pp. 1697-702, 1991.
L. E. Bermudez, Martinelli, J., Petrofsky, M., Kolonoski, P., and Young, L. S., Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model., The Journal of infectious diseases, vol. 169, no. 3, pp. 575-80, 1994.
L. E. Bermudez and Young, L. S., Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex., Journal of leukocyte biology, vol. 48, no. 1, pp. 67-73, 1990.

Pages